Indo US Bio-Tech (BOM:541304) Total Current Assets : ₹0.0 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Indo US Bio-Tech Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Indo US Bio-Tech's total current assets for the quarter that ended in Dec. 2024 was ₹0.0 Mil.

Indo US Bio-Tech Total Current Assets Historical Data

The historical data trend for Indo US Bio-Tech's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Total Current Assets Chart

Indo US Bio-Tech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Current Assets

Get a 7-Day Free Trial

319.00

381.35

468.38

381.35

468.38

Indo US Bio-Tech Quarterly Data
	Mar17	Oct17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Jun22	Sep22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24
Total Current Assets	Get a 7-Day Free Trial															670.46	-	468.38	764.20	-

Indo US Bio-Tech Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Indo US Bio-Tech's Total Current Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.492	+	205.467	+	233.571	+	28.851
	=	468.4

Indo US Bio-Tech's Total Current Assets for the quarter that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0	+	0	+	0	+	0
	=	0.0

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Indo US Bio-Tech (BOM:541304) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Indo US Bio-Tech's Liquidation Value for the quarter that ended in Dec. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	0	+	0.75 * 0	+	0.5 * 0
=	0.0

Indo US Bio-Tech Total Current Assets Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo US Bio-Tech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (BOM:541304) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

INDOUS:India

Address

Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061

Website

https://www.indousagriseeds.com

Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.

Indo US Bio-Tech Headlines

No Headlines